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Highlights  
 
- A Delphi process was conducted with experts in paediatric status epilepticus 
- 9 consensus high priority questions were identified 
- Future research efforts should be directed towards these priority areas. 
 
Abstract and Key Words: (254 words) 
Purpose: Status epilepticus  (SE) is a paediatric emergency with significant morbidity 
and mortality. Recommendations beyond first line care are not based on high quality 
evidence. Emergency physicians and neurologists are key stakeholders in managing 
this condition.  A collaborative, widely consulted approach to identifying priorities 
can help direct limited research funds appropriately. The objectives of this study are 
to identify consensus research priorities in paediatric SE among experts and health 
consumers.  
Methods: A three-stage Delphi process was conducted.  Paediatric Neurologists and 
Emergency Physicians in Australia and New Zealand participated.  Round one asked 
participants to generate three research questions important for further research in 
paediatric status epilepticus.  Responses were refined into unique individual 
questions. Rounds two and three required participants to rate questions on a seven 
point ordinal scale. Health consumers were invited to participate by providing up to 
three problem areas that could be addressed by research.   
Results: 54 experts and 76 health consumers participated in the process.  Nine 
questions reached our definition of consensus “high priority”, 21 questions achieved 
consensus “low priority” and seven questions did not achieve consensus.  High 
priority areas included second line management including levetiracetam (efficacy, 
dose and timing), use of third line agents, induction of anaesthesia (timing and best 
agent), management of focal SE, and indicators of “subtle SE”.  Consumer priority 
areas included themes of treatment efficacy, aetiology, and community education. 
Conclusion: We identified nine priority research questions in paediatric SE, 
congruent with the health consumer theme of treatment efficacy.  Future research 
efforts should be directed towards these priority areas.  
Key Words: Status epilepticus, consensus, paediatric, seizures 
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Introduction 
Status epilepticus (SE) is the most common childhood neurological emergency and is, 
with its underlying aetiology, associated with an estimated mortality of 3% and 
significant morbidity1, 2 including development of focal neurological deficits, 
cognitive impairment, behavioural problems or epilepsy3.  The incidence of paediatric 
SE is in the order of 20 per 100,000 population at risk1, 4.  Aetiology and outcomes of 
SE in children are different from adults4; therefore adult evidence is minimally 
applicable to paediatric settings. An operational definition of SE based on the 
indication to commence treatment has been proposed for seizures of five minutes or 
more5, replacing the “traditional” definition requiring seizures of greater than 30 
minutes duration or two or more sequential seizures without full recovery of 
consciousness between seizures.  These concepts have been incorporated into recent 
clinical trials6 and conceptually into recent consensus documents7. 
Benzodiazepines are widely used in the first line pharmacological management of SE, 
supported by good evidence of efficacy, but recommended subsequent management is 
based on expert opinion, tradition and consensus8. Despite the considerable burden of 
SE, addressing important clinical questions is challenging with single centre studies, 
and generally requires a collaborative approach with considerable resources and 
infrastructure9. A collaborative, consultative and systematic approach to identify and 
clarify the immediate research priorities in SE is indicated to ensure limited research 
funds are directed appropriately.  Incorporating stakeholders’ perspectives into the 
development of research priorities might lead to highly engaged researchers and 
increased likelihood of translating  research into clinical practice. 
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The Delphi technique is a common approach for the solicitation and collation of 
opinions from experts in a particular field in the development of ideas and priorities. 
The Delphi technique has been widely used in health sciences research and is 
appropriate to correlate informed judgements on topics spanning the disciplines of 
neurology and emergency medicine.  Briefly, the technique involves a set of 
sequential questionnaires, with information from previous responses summarised and 
fed back to participants10. The first round usually consists of open ended questions 
soliciting specific information about the content of subsequent structured 
questionnaires.  Three to six rounds are usually employed to reach consensus on a 
topic10. The technique has been successfully used to identify research priorities in the 
field of paediatric neurology11, paediatrics12 and paediatric emergency medicine13, 14.  
The perspective of emergency physicians is perhaps historically underrepresented in 
SE literature and guideline development, despite being responsible for the majority of 
acute care decisions in SE in many health systems. It is also imperative that health 
consumers (i.e. patients and families of patients) are represented to ensure that 
community expectations about research priorities are met.  
The primary objective of this study was to use the Delphi technique to achieve 
consensus on research priorities in the management of paediatric SE among paediatric 
neurologists and emergency physicians who treat children.  A secondary objective 
was to determine if research priorities identified by experts aligned with priorities 
identified by health consumers.  The results of this study will help determine where to 
allocate scarce research resources to achieve better outcomes for patients.  
Methods 
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This was an assessment of expert clinician and health consumer opinion via a Delphi 
survey to identify research priorities for paediatric SE.  The survey was conducted 
with the support of the Australia and New Zealand Child Neurology Society 
(ANZCNS) and Paediatric Research in Emergency Departments International 
Collaborative (PREDICT) network.  
Participants 
Expert participants were paediatric neurologists and emergency physicians in 
Australia and New Zealand.  An invitation to participate was distributed to paediatric 
neurologists through the ANZCNS by email, explaining the purpose of the study, the 
expected time commitment, the proposed number of rounds and timelines.  
Emergency physicians were invited to participate through site representatives of the 
PREDICT network.  Site representatives at PREDICT sites were asked to nominate 
interested clinicians, and provide email details, to approximate respondent numbers 
from neurologists to maintain balance and representation of both groups and inclusion 
of perspectives of non-researchers. Although controversy exists as to what constitutes 
the ideal number of subjects in a Delphi study15-18, it has been recommended that one 
should have 30 experts from any one discipline, or at least 10 per category for 
different professional disciplines. It has been suggested that increasing a group size 
beyond 30 does not generally improve results16. A total sample of at least 30 
respondents was sought, allowing for attrition.   
Consumer participants included health consumers with a diagnosis of epilepsy and a 
prior SE event, as well as their families. Information regarding the study objectives 
was distributed through Epilepsy Queensland social media webpages, with an 
explanatory sheet, and a link to participation in the survey.  
AC
CE
PT
ED
 M
AN
US
CR
IPT
  
Study Procedure and Design 
Surveys were constructed and distributed electronically via email, using 
SurveyMonkey19. In round one clinical participants were asked to identify research 
priorities in the field of paediatric SE that they believed was lacking by answering one 
single open question: “Thinking about your experience with paediatric convulsive 
status epilepticus, what are the most important research questions that need 
addressing”.  The survey allowed for free text responses, and participants were 
encouraged to submit the research questions in the PICO format (referring to 
Population, Intervention, Comparison, Outcome).  They were given three weeks in 
which to respond and could submit up to three questions. Non-responders were 
emailed a reminder at one and two weeks after initial contact. Consumers were asked 
to provide up to three problem areas associated with paediatric status epilepticus that 
could/should be addressed by research.  Demographic details were collected from 
both experts and consumers.  
Definitions of SE have been somewhat contentious and continue to evolve7.  In the 
survey information we defined SE simply as an “abnormally long seizure” 
operationally defined as when emergency treatment should be started e.g. beyond 5 
minutes for tonic-clonic SE. Questions concerning “children” referred to ages 1 
month to 16 years, and “infants” as ages 1 month to 12 months. 
Questions generated by round one were collated into themes, and developed into 
mutually exclusive research questions using NVivo 11 for Mac (NVivo qualitative 
data management Software; QSR International Pty Ltd. Version 10, 2014).  Analysis 
of responses to round one used a grounded theory approach and a process of content 
analysis and open coding to categorize items into themes17. The compiled proposed 
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questions were reviewed and refined by the investigator team and included in round 
two in a structured questionnaire.  The investigator team included experienced 
paediatric emergency physicians, paediatric neurologists, clinician researchers and 
methodological expertise. Surveys were pilot tested for face validity on a group of ED 
physicians and paediatricians and amended as required.  In round two participants 
were asked to rate the perceived priority of each research question using a seven point 
Likert-type, ordinal scale (Very low priority, low priority, fairly low priority, neutral, 
fairly high priority, high priority, very high priority).  Participants were also 
encouraged to supply reasoning and further comments.   
Round three consisted of the questions from round two that did not reach 
predetermined criteria for consensus “high” or “low” priority, together with a 
summary of feedback for each question including scores and text comments to allow 
responders to reflect on colleagues scores and thoughts.  In round three participants 
were again asked to rate the perceived priority of each research question using the 
same seven point Likert-type/ordinal scale.      
Analysis plan and statistical considerations 
Data from round two and three were exported to an excel spread sheet and analysed 
on SPSS (Ver 20.0, IBM, Armonk, NY, USA).  Overall support for group responses 
to questions were reported as means and standard deviation. Consensus priority was 
defined as more than 70% of total respondents rating a question as “fairly high 
priority” or higher20.  Consensus “non priority” questions were defined as questions 
where more than half of the respondents rated the questions as “neutral” or lower 
priority. The pragmatic decision was made to stop the process at three rounds, 
considering the low likelihood of achieving consensus with further rounds and survey 
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response fatigue, based on previous work suggesting that additional rounds produce 
minimal change in opinion10, 16.   
Consumer participants completed a specifically developed questionnaire, and were 
asked to list three “questions or ideas for research” which they believe are important 
for children with convulsive status epilepticus.   Responses were exported and 
qualitative thematic analysis was performed using NVivo 11 for Mac (NVivo 
qualitative data management Software; QSR International Pty Ltd. Version 10, 2014).  
These are reported separately and assessed for theme concordance with priorities 
identified by experts. 
Ethics and Consent 
The study was approved by the Townsville Hospital Human Research Ethics 
Committee.  Consent of experts was implied when participants responded to the 
survey via the survey portal.  Consumers were given the opportunity to discuss 
participation with a member of the research team at a mutually convenient time if 
required, and asked to check a box on the survey instrument indicating consent to 
participate.  
Results 
Experts 
The three round Delphi process was conducted from April to December 2016. The 
survey remained open for 4 weeks for each round, with ten weeks between rounds for 
analysis and development of subsequent surveys. Fifty-four experts agreed to 
participate in the Delphi process and provided questions and valid email address for 
subsequent rounds. The demographics of “expert” participants are shown in table 1. 
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Response rates for round two and three were 42/54 (78%) and 44/54 (81%) 
respectively.   
Questions from round one were imported into NVivo, coded and developed into 37 
unique questions in seven categories consisting of: first line agents, second line 
agents, timing of second line agents, induction of anaesthesia/intubation, home and 
pre-hospital care, investigation of SE, and general issues.   
The results of ranking the 37 questions constituting round 2 of the Delphi process are 
summarised in table S1 (Supplementary appendix) together with the proportion of 
responses that rated the question as greater or equal to “fairly high priority” or 4 on 
the scale.  Six questions met our definition of high priority consensus (table 3), while 
15 questions met our definition for low priority consensus.  The remaining 16 
questions that did not reach consensus were refined, and with feedback included in 
the round 3 survey.  
In round 3 a further 3 of 16 questions achieved high priority consensus (table 3), and 
6 questions reached low priority consensus, and seven questions failed to reach 
consensus (intermediate priority).  Round 2 and 3 responses are summarised in table 4 
and S1.  In addition to rating the perceived priority of each research question, 
participants were able to provide comments and additional insights in a free text 
response.  Indicative quotes accompanying questions achieving high priority status 
are included in table S2.  
Health consumers 
The consumer survey was made available from August to November 2016 and 
received 76 responses. Demographics of health consumer participants are shown in 
AC
CE
PT
ED
 M
AN
US
CR
IPT
  
table 2, and included people with epilepsy and family members of people with 
epilepsy; a high proportion had previous experience of status epilepticus.  Over 100 
questions or ideas were generated by the consumer survey.  The most common 
themes included drug therapies and treatment efficacy, causes and “triggers”, and 
outcomes and prognostication (table 4).  Less common themes (six responses) 
concerned medicinal cannabis and education of public and community in general.  
Discussion 
The Delphi consensus process involving expert emergency physicians and paediatric 
neurologists identified nine priority research questions for the management of 
paediatric status epilepticus.  Three questions specifically concerned the use of 
levetiracetam, another concerned the timing of “second line agents” including 
levetiracetam, and two questions referred to induction of anaesthesia. These were 
broadly congruent with the “drug therapies” priority theme commonly identified by 
health consumers. Other questions concerned clinical indicators of subtle SE and 
management of focal SE. 
Experts prioritised a comparative efficacy and safety study between levetiracetam and 
phenytoin in both infants and children (table 3, questions 1 and 2).  Many were aware 
that studies to address this issue were underway in Australia and New Zealand, the 
United States and the United Kingdom21, 22.  This finding confirms that these results 
are keenly anticipated, and are likely to affect management algorithms internationally.  
A separate research question that may not be adequately addressed by current trials 
was for the most appropriate dose of levetiracetam (table 3, question 7).  Current trials 
are investigating doses of 40mg/kg to 60 mg/kg of levetiracetam21, 22.   Of interest, 
pre-hospital use of levetiracetam was not considered a research priority (intermediate 
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priority) and second line usage of sodium valproate was of low consensus priority in 
round three.  This may reflect unfamiliarity of the drug due to limited availability of 
the intravenous formulation in Australia and New Zealand, or concerns about safety 
in certain subpopulations, particularly infants.  Again, it is likely that on-going trials 
will address this question in children older than two years. Other “newer” second line 
agents such as lacosamide were not proposed as priority research questions in our 
study.  
Another research priority was the use of second line agents, such as levetiracetam 
earlier in the algorithm (table 3, question 4).  This has been advocated by some 
experts in the literature, including “combination” therapy, and may be facilitated if 
agents associated with less side effects (e.g. levetiracetam, sodium valproate, 
lacosomide) are found to be non-inferior to standard therapies.  A trial in adults did 
not demonstrate benefit of the addition of levetiracetam to clonazepam in adult 
patients with SE in a pre-hospital trial in France23. 
Identifying clinical indicators of subtle SE when electroencephalogram (EEG) is not 
available was also identified as a high priority question (question 5, table 3). 
Differentiating ongoing subtle SE from the postictal state can create difficulty in the 
acute setting, especially in children who may have baseline abnormal neurological 
function. EEG support in this setting is limited by access to urgent EEG, and the time 
taken to set up a recording. There are potential adverse consequences from under or 
over diagnosis of subtle SE (such as excessive SE treatment including intubation, and 
later long term medication and lifestyle restrictions advice that are based on the 
reported duration of seizure). Some respondents commented that there were perhaps 
no reliable clinical indicators of subtle SE. Other respondents, however, commented 
that increasing expert support at the point of clinical decision making regarding subtle 
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SE, through review of the patient by experts in subtle SE (by acute video review or 
neurologist telemedicine consultation) could address this problem, at least in a 
proportion of SE cases. 
Management of focal SE and whether algorithms should be similar to convulsive SE 
was also a high priority (table 3, question 6).  While recent consensus documents have 
indicated that different operational time frames are applied to focal SE to tonic-clonic 
SE, it was conceded that this was based on limited data7. Our results indicate that 
clinicians require further clarity in terms of management strategies in this area and 
may warrant further study. 
Induction of anaesthesia was also a high priority area for clinicians (table 3, questions 
3 and 8).  Whether early induction of anaesthesia improved outcomes achieved 
consensus with high levels of support, but divided opinion in comments with some 
suggesting it may be unethical (Table S2).  Other experts commented that their 
clinical experience suggests practice in this regard is already highly variable, as 
indicated in observational data therefore it is valid to pursue this as a research priority.  
Conversely, the use of third line agents rather than induction of anaesthesia, a strategy 
that observational trials suggest is commonly used was also found to be a research 
priority (table 3, question 9). Additionally, the preferred induction agent was 
identified as a high priority in round three of the process, with a lack of quality 
evidence cited.  An attempt to investigate this question in adults, comparing Propofol 
to Barbiturates failed to demonstrate a difference, but this was predominantly due to 
poor recruitment and early closure of trial24.  A similar study in children may prove 
equally difficult, and perhaps methodologies other than RCTs may be required 
initially. Use of Ketamine and Propofol in the non-intubated patient were both judged 
to be low priority questions, although proponents may argue they may have a role in 
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specific circumstances e.g. when it is highly desirable to avoid intubation as with 
frequent recurrent SE.  
In 2014 the U.S. Pediatric Status Epilepticus Research Group (pSERG) published a 
report summarizing the evidence of paediatric SE and refractory convulsive SE9.  
Based on their literature review, the group identified several knowledge gaps 
including risk factors for SE, biomarkers, second and third line treatment options and 
long-term outcome9.  While the methods used by pSERG differed from our consensus 
Delphi approach, and knowledge gaps do not necessarily equate with research 
priorities, the congruence with priorities identified in our study reinforce the 
importance of our findings.  
 
There were some differences between consumer and expert responses.  Apart from the 
theme of treatment efficacy, consumer priority themes included “triggers” or causes, 
prognosis as well as medicinal cannabis and education.  Differences may be partly 
explained by unique perspectives on SE.  For example emergency physicians may be 
less likely to consider preventative strategies, however these are clearly no less 
valuable. The themes identified by consumers are illustrative of the issues important 
to people and their families affected by epilepsy, and future work can build on these 
ideas.  
 
Our study had strengths and limitations. The Delphi process is widely used in health 
sciences.11-14  The major benefits of the technique are to avoid the limitations of using 
less formal techniques to achieve consensus such as through committees and panels, 
which can be prone to domination by powerful individuals and influenced by 
personalities.  The benefits of anonymity and confidentiality contribute to the 
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development of true expert consensus17, 20.  Other advantages include that the process 
allows participants to generate additional insights and more thoroughly clarify 
information.  Other methods of generating consensus opinions, and generating 
research priorities have been used, and include the Nominal Group Technique and the 
Hanlon Prioritisation Process13, 25-27.  The Delphi approach was considered the most 
appropriate in our circumstance, as experts were geographically dispersed and were 
not required to physically meet.   
Limitations of our study included that our process of identifying and defining expert 
panellists for the sampling frame was somewhat subjective, and the Delphi technique 
works on the assumption that participants are equal in knowledge and experience, 
which may not be correct.  However, involvement of emergency physicians and 
paediatric neurologists in this process was a strength of the design.  A further concern 
is that minority opinion might be lost, and yet still have value.  Participants had the 
opportunity to add comments that were handled in a qualitative analysis of responses. 
We do not contend that just because a research question did not achieve a consensus 
high priority by our process, that it is without value or incapable of contributing 
important knowledge or benefit to patients.   
While a strength of the study was the inclusion of health consumers, our methods may 
have introduced some selection bias.  Respondents identified through epilepsy support 
organisations likely represent patients with more severe or burdensome established 
epilepsy, only a subgroup of the children presenting with SE. This may have lead to 
some bias towards responses specific to chronic epilepsy and may account for 
differences in responses from experts.  We did not seek the consensus of consumers 
through classic Delphi technique in this group, rather evaluated concordance with the 
consensus of experts.   
AC
CE
PT
ED
 M
AN
US
CR
IPT
  
There is no “gold standard” for defining consensus during a Delphi process, and 
various definitions have been proposed17, 20.  Methods used in our study had been 
advocated and used in similar studies11, 15, 16, 20. Further limitations are inherent with 
any research involving surveys and rating scales include the central tendency bias, 
where participants tend to avoid rating at the extremes of the scales, acquiescence bias 
and social desirability bias.   
Finally, in our instructions to participants we specifically excluded the neonatal 
period, for similar reasons that adult SE was excluded. In these age groupings SE was 
considered to have different aetiologies and outcomes, therefore results of this study 
are not applicable to the neonatal population.  This research only involved participants 
in Australia and New Zealand, a region with an advanced health system, with high 
standards of education and training, therefore results should be generalizable to other 
developed countries.  
In summary, we sought to achieve consensus on research priorities in the management 
of paediatric SE.  Our consensus process allowed experts to identify nine high priority 
research questions consisting of second line management including levetiracetam 
(efficacy, dose and timing), use of third line agents, induction of anaesthesia (timing 
and best agent), management of focal SE, and indicators of “subtle SE” concordant 
with consumer priorities.  Results of this research should help inform where future 
research efforts in paediatric SE should be directed.   
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Table 1. Demographic details of respondents to expert survey. 
 
 n (%) 
Gender 
    Female 21 (39%) 
Age Range 
    25-34 1   (2%) 
    35-44 26 (48%) 
    45-54 20 (37%) 
    55+ 7   (13%) 
Years since medical graduation 
    Median 21 (IQR 16 to 26) 
Speciality 
    Emergency physician 22 (41%) 
    Paediatric Neurologist 32 (59%) 
Hospital category 
   Tertiary 43 (80%) 
   Secondary 5    (9%) 
   Both  6   (11%) 
Full time / Part time 
   Full time 39 (72%) 
   Part time 15  (28% )  
 IQR interquartile range, all  
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Table 2. Demographic details of respondents to consumer survey. 
 
 n (% ) 
Gender 
  Female 68 (89%) 
Age Range 
  18-24 7   (9%) 
  25-34 13 (17%) 
  35-44 27 (35%) 
  45-54 16 (21%) 
  55+ 13 (17%) 
Highest level of education attained 
  School certificate (Year 10) 12 (16%) 
  Higher school certificate (Year 12) 13 (17%)  
  Post school, non-university 23 (30%)  
  Undergraduate university degree 20 (26%)  
  Postgraduate university degree 8  (11%) 
Religious preference 
  Christianity 42 (55%) 
  No religion 33 (43%) 
  Islam 1   (1%) 
Approximate annual household income 
  Less than $25K 14 (18%) 
  $25-49K 15 (19%) 
  $50-74K 14 (18%) 
  $75-100K 15 (19%) 
  More than $100K 18 (24%) 
Diagnosis of epilepsy 
  Self 34  (45%) 
  Child 37  (49%)  
  Sibling 2    (3%) 
Previous episodes of status epilepticus 
  Yes 58 (76%) 
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Table 3. Consensus high priority questions, rankings and scores. 
 
Questions 
Round 2 Round 3 
%  ≥ 
4* 
Mea
n 
(SD
) 
% ≥ 
4* 
Mean 
(SD) 
1. In infants with convulsive SE, is levetiracetam superior to phenytoin 
(or phenobarbitone) for efficacy (seizure termination) and safety 
(adverse effects)? 
85% 5.3 
(1.1
) 
  
2. In children with convulsive SE, is levetiracetam superior to 
phenytoin for efficacy (seizure termination) and safety (adverse 
effects)? 
82% 5.5 
(1.3
) 
  
3. In children with convulsive SE is the early use of anaesthesia 
associated with more rapid seizure terminations, less complications 
and better long-term outcomes, compared to anticonvulsant treatment 
alone? 
82% 5.2 
(1.2
) 
  
4. In children with convulsive SE, is earlier administration of a second 
line agent (e.g. levetiracetam) more effective than standard protocols? 
74% 4.9 
(1.1
) 
  
5. If EEG is not available, what are the most reliable clinical indicators 
of ongoing subtle SE? 
73% 4.9 
(1.4
) 
  
6. In children with focal SE should the medical management proceed 
according to similar treatment pathways as for convulsive SE, and 
within the same time frames? 
72% 4.7 
(1.1
) 
  
7. In children with convulsive SE, what is the most appropriate dose of 
levetiracetam as a second line agent?  
68% 5.0 
(1.2
) 
77% 4.9 
(1.2) 
8. In children with convulsive SE who require intubation, what 
induction agent is most effective for seizure termination, long-term 
outcome and complications (e.g. ketamine, propofol, thiopentone, 
other)?  
68% 4.8 
(1.1
) 
81% 5.1 
(1.2) 
9. In children with convulsive SE, Is third line medical anticonvulsant 
drugs compared with induction of anaesthesia and intubation 
associated with improved long-term outcomes? 
66% 4.9 
(1.2
) 
81% 5.1 
(1.0) 
*Denotes percentage of respondents who ranked question fairly high priority (4 on 
scale) or higher. SD standard deviation. 
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Table 4. Consumer survey data.  Common themes, counts and indicative quotes.   
 
Drug Therapies and treatment efficacy (20 references) 
“optimal agent /timing” 
“Most effective treatment” 
“maximal safe pre-hospital care” 
“A simpler easy to use rescue medication as an alternative to what is available if available meds 
don't work.” 
Causes and Triggers (19 references) 
“What causes it” 
“Research the triggers and warning signals to help parents be proactive in preventing status 
episodes from occurring.” 
“What are the major triggers for CSE?” 
Outcomes and prognosis (18 references) 
“What are the long term cognitive effects of these episodes?” 
“Neuropsych testing for school performance” 
“What harm can occur” 
Medicinal cannabis (6 references) 
“Would medically approved marijuana help” 
“get cannabis oil legalised not just for children” 
Education (3 responses) 
“More education for nursing and other medical staff on how to deal with status episodes” 
“Community education around responding to status epilepticus for non-primary carers” 
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